629 related articles for article (PubMed ID: 18162355)
1. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.
Rao RN; Raju AN; Narsimha R
J Sep Sci; 2008 Jun; 31(10):1729-38. PubMed ID: 18481321
[TBL] [Abstract][Full Text] [Related]
3. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
4. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of stability-indicating HPLC and UPLC methods for the determination of bicalutamide.
Nanduri VV; Adapa VS; Kura RR
J Chromatogr Sci; 2012 Apr; 50(4):316-23. PubMed ID: 22407342
[TBL] [Abstract][Full Text] [Related]
6. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
Chitturi SR; Somannavar YS; Peruri BG; Nallapati S; Sharma HK; Budidet SR; Handa VK; Vurimindi HB
J Pharm Biomed Anal; 2011 Apr; 55(1):31-47. PubMed ID: 21316175
[TBL] [Abstract][Full Text] [Related]
7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
8. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
9. An improved and validated LC method for resolution of bicalutamide enantiomers using amylose tris-(3,5-dimethylphenylcarbamate) as a chiral stationary phase.
Nageswara Rao R; Narasa Raju A; Nagaraju D
J Pharm Biomed Anal; 2006 Sep; 42(3):347-53. PubMed ID: 16750608
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a simple and sensitive high performance liquid chromatographic method for the simultaneous determination of anastrozole, bicalutamide, tamoxifen, and their synthetic impurities.
Gomes FP; Garcia PL
Talanta; 2012 Nov; 101():495-503. PubMed ID: 23158354
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of process related impurities of olanzapine using HPLC and ESI-MS/MS.
Rao RN; Raju AN; Narsimha R; Babu GR
J Sep Sci; 2008 Jan; 31(1):107-18. PubMed ID: 18080239
[TBL] [Abstract][Full Text] [Related]
12. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a highly sensitive LC-MS/MS-ESI method for the determination of bicalutamide in mouse plasma: application to a pharmacokinetic study.
Sharma K; Pawar GV; Giri S; Rajagopal S; Mullangi R
Biomed Chromatogr; 2012 Dec; 26(12):1589-95. PubMed ID: 22495777
[TBL] [Abstract][Full Text] [Related]
14. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
Nageswara Rao R; Kumar Talluri MV; Shinde DD
J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals.
Nageswara Rao R; Nagaraju D; Alvi SN; Bhirud SB
J Pharm Biomed Anal; 2004 Nov; 36(4):759-67. PubMed ID: 15533668
[TBL] [Abstract][Full Text] [Related]
18. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
Zhou H; Tai Y; Sun C; Pan Y
J Pharm Biomed Anal; 2005 Feb; 37(1):97-107. PubMed ID: 15664748
[TBL] [Abstract][Full Text] [Related]
19. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
Hadad GM
J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
[TBL] [Abstract][Full Text] [Related]
20. High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats.
Singh AK; Chaurasiya A; Jain GK; Awasthi A; Asati D; Mishra G; Khar RK; Mukherjee R
Talanta; 2009 Jun; 78(4-5):1310-4. PubMed ID: 19362193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
